Intravenous (IV) Solution Market Highlights
Intravenous (IV) Solution is also known as IV fluid or drip. It is administered intravenously in various treatments including dehydration, treatment of infection using antibiotics, and chronic diseases. In cancer treatments chemotherapy drugs, pain management and certain medications are administered intravenously.
Over the past few years, the intravenous solution market has been growing rapidly, mainly due to the increasing prevalence of chronic diseases. Besides, the adoption of heady & unhealthy lifestyles is escalating the market demand, mirroring the prevalence of damaged immune system and various disorders.
According to Market Research Future (MRFR), the global intravenous (IV) solution market is poised to reach a valuation of USD 11,511.2 MN. by 2022. In its recently published report, MRFR also asserts that the market would register a CAGR over 7.69% throughout the forecast period (2016 to 2022).
Latest Free Sample PDF Available Here !! https://www.marketresearchfuture.com/sample_request/1235
Additional factors, such as immense stress, lack of good quality sleep, inadequate & improper diet, and sedentary lifestyle are fueling the growth of the market, leading to immunodeficiency disorders. Also, increasing R&D funding, rapidly developing healthcare infrastructure, and increasing healthcare expenditures are some of the major driving forces supporting the growth of the market. Advancements in medical technologies & medical science are fostering the market growth exponentially, bringing up novel treatment procedures, & medications. Furthermore, the growing population and geriatric populace worldwide substantiate the demand in the market demand, prompting the need for effective medical treatments. The improving economic conditions are providing impetus to the market growth, enabling access to the quality life & improved healthcare. Besides, seminal efforts & investments transpired in the development of IV solution, by the key market players are paying off well, driving the growth of the market.
Intravenous (IV) Solution Market – Segments
The report is segmented into four market dynamics to widen the scope of understanding,
By Type : Peripheral Parenteral Solution and Total Parenteral Solution, among others.
By Nutritional Contents: Carbohydrates, Amino Acid Solution, Parenteral Lipid Emulsion, and Vitamins & Minerals, among others.
By End-users : Ambulatory Service Centers, Hospitals & Clinics, and Homecare, among others.
By Regions : Europe, North America, Asia Pacific, and the Rest-of-the-World.
Global Intravenous Solution Market – Geographical Analysis
North America is leading the global intravenous solution market, accounting for the largest revenue pocket. The high consumption rate of IV solution due to the high prevalence of chronic diseases is predominantly driving the growth of the regional market. Moreover, factors, such as the increasing prevalence of immunodeficiency disorder and rising demand for treatment measures provide impetus to the regional market growth.
The IV solution market in the US driven by high healthcare expenditures leads the market growth in the region.
The intravenous solution market in the European region stands second on the global platform. The market is fostered by the increasing per capita healthcare expenses and the proliferation of healthcare sector in the region. Growing markets in European countries such as Germany and France drive the market IV solution market in the region, at a large scale. Besides, increasing investment in healthcare and the rising number of patients with chronic diseases are projected to support the regional market growth during the forecast period.
The Asia Pacific intravenous solution has emerged as a profitable market. Owing to the burgeoning healthcare sector and medical treatment market in India and China, the region is expected to perceive an exponential growth over the assessment period. Furthermore, the presence of high-quality and better healthcare infrastructure and institutions in the region would support the APAC intravenous solution market to register a CAGR of 8.34% throughout the forecast period (2016 to 2022).
Global IV Solution Market – Competitive Analysis
Fiercely competitive, the IV solution market appears to be fragmented with the presence of several large and small players. Players acquire small yet promising companies, mostly in emerging markets, to expand their footprints. To improve their market performance, they are also adopting strategic approaches, such as M&A, collaboration, and product launch.
Players leading the IV solution market include B. Braun Melsungen AG (Germany), Fresenius Kabi AG (Germany), ICU Medical, Inc. (US), Amanta Healthcare (India), Terumo Medical Corporation (Tokyo), Baxter (US), and Grifols S.A. (Spain), among others.
Industry, Innovation & Related News
July 24, 2019 —- Cipla USA Inc. (the US), a pharmaceutical company announced the acquisition of the prescription drug ZEMDRI (Plazomicin) from Achaogen Inc. ZEMDRI™ is a novel intravenous (IV) aminoglycoside for the treatment of cUTI and others. It was approved by the USFDA in June 2018, and launched in the same year, with patent protection expected to continue until 2031 or 2032.
The acquisition gives Cipla worldwide rights of ZEMDRI™ (excluding Greater China) with its allied assets and limited liabilities. Additionally, the addition of key anti-infective ZEMDRI™ furthers Cipla’s AMR stewardship, deepening its pipeline of specialty products in the US.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
+1 646 845 9312